Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2084009328', 'doi': 'https://doi.org/10.1200/jco.2003.04.057', 'title': 'Randomized, Multicenter, Phase II Trial of Two Multicomponent Regimens in Androgen-Independent Prostate Cancer', 'display_name': 'Randomized, Multicenter, Phase II Trial of Two Multicomponent Regimens in Androgen-Independent Prostate Cancer', 'publication_year': 2003, 'publication_date': '2003-02-27', 'ids': {'openalex': 'https://openalex.org/W2084009328', 'doi': 'https://doi.org/10.1200/jco.2003.04.057', 'mag': '2084009328', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/12610188'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1200/jco.2003.04.057', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S15137598', 'display_name': 'Journal of Clinical Oncology', 'issn_l': '0732-183X', 'issn': ['0732-183X', '1527-7755'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5027897588', 'display_name': 'Randall E. Millikan', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210165485', 'display_name': 'Columbus Community Clinical Oncology Program', 'ror': 'https://ror.org/05rvv6a54', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I4210165485']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Randall Millikan', 'raw_affiliation_strings': ['From the Genitourinary Medical Oncology Department and Department of Biostatistics, University of Texas M.D. Anderson Cancer Center, Houston, TX; Cancer Center of Wichita/Clinical Community Oncology Program, Wichita, KS; Cancer Center of Columbus/Clinical Community Oncology Program, Columbus, OH; and Central Illinois Clinical Community Oncology Program, Decatur, IL.'], 'affiliations': [{'raw_affiliation_string': 'From the Genitourinary Medical Oncology Department and Department of Biostatistics, University of Texas M.D. Anderson Cancer Center, Houston, TX; Cancer Center of Wichita/Clinical Community Oncology Program, Wichita, KS; Cancer Center of Columbus/Clinical Community Oncology Program, Columbus, OH; and Central Illinois Clinical Community Oncology Program, Decatur, IL.', 'institution_ids': ['https://openalex.org/I4210165485']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5002347804', 'display_name': 'Peter F. Thall', 'orcid': 'https://orcid.org/0000-0002-7293-529X'}, 'institutions': [{'id': 'https://openalex.org/I4210165485', 'display_name': 'Columbus Community Clinical Oncology Program', 'ror': 'https://ror.org/05rvv6a54', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I4210165485']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Peter F. Thall', 'raw_affiliation_strings': ['From the Genitourinary Medical Oncology Department and Department of Biostatistics, University of Texas M.D. Anderson Cancer Center, Houston, TX; Cancer Center of Wichita/Clinical Community Oncology Program, Wichita, KS; Cancer Center of Columbus/Clinical Community Oncology Program, Columbus, OH; and Central Illinois Clinical Community Oncology Program, Decatur, IL.'], 'affiliations': [{'raw_affiliation_string': 'From the Genitourinary Medical Oncology Department and Department of Biostatistics, University of Texas M.D. Anderson Cancer Center, Houston, TX; Cancer Center of Wichita/Clinical Community Oncology Program, Wichita, KS; Cancer Center of Columbus/Clinical Community Oncology Program, Columbus, OH; and Central Illinois Clinical Community Oncology Program, Decatur, IL.', 'institution_ids': ['https://openalex.org/I4210165485']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100735238', 'display_name': 'Sang Joon Lee', 'orcid': 'https://orcid.org/0000-0001-7513-5733'}, 'institutions': [{'id': 'https://openalex.org/I4210165485', 'display_name': 'Columbus Community Clinical Oncology Program', 'ror': 'https://ror.org/05rvv6a54', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I4210165485']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Sang-Joon Lee', 'raw_affiliation_strings': ['From the Genitourinary Medical Oncology Department and Department of Biostatistics, University of Texas M.D. Anderson Cancer Center, Houston, TX; Cancer Center of Wichita/Clinical Community Oncology Program, Wichita, KS; Cancer Center of Columbus/Clinical Community Oncology Program, Columbus, OH; and Central Illinois Clinical Community Oncology Program, Decatur, IL.'], 'affiliations': [{'raw_affiliation_string': 'From the Genitourinary Medical Oncology Department and Department of Biostatistics, University of Texas M.D. Anderson Cancer Center, Houston, TX; Cancer Center of Wichita/Clinical Community Oncology Program, Wichita, KS; Cancer Center of Columbus/Clinical Community Oncology Program, Columbus, OH; and Central Illinois Clinical Community Oncology Program, Decatur, IL.', 'institution_ids': ['https://openalex.org/I4210165485']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102192012', 'display_name': 'Donnah Jones', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210165485', 'display_name': 'Columbus Community Clinical Oncology Program', 'ror': 'https://ror.org/05rvv6a54', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I4210165485']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Donnah Jones', 'raw_affiliation_strings': ['From the Genitourinary Medical Oncology Department and Department of Biostatistics, University of Texas M.D. Anderson Cancer Center, Houston, TX; Cancer Center of Wichita/Clinical Community Oncology Program, Wichita, KS; Cancer Center of Columbus/Clinical Community Oncology Program, Columbus, OH; and Central Illinois Clinical Community Oncology Program, Decatur, IL.'], 'affiliations': [{'raw_affiliation_string': 'From the Genitourinary Medical Oncology Department and Department of Biostatistics, University of Texas M.D. Anderson Cancer Center, Houston, TX; Cancer Center of Wichita/Clinical Community Oncology Program, Wichita, KS; Cancer Center of Columbus/Clinical Community Oncology Program, Columbus, OH; and Central Illinois Clinical Community Oncology Program, Decatur, IL.', 'institution_ids': ['https://openalex.org/I4210165485']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5006101210', 'display_name': 'Michael W. Cannon', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210165485', 'display_name': 'Columbus Community Clinical Oncology Program', 'ror': 'https://ror.org/05rvv6a54', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I4210165485']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'M.W. Cannon', 'raw_affiliation_strings': ['From the Genitourinary Medical Oncology Department and Department of Biostatistics, University of Texas M.D. Anderson Cancer Center, Houston, TX; Cancer Center of Wichita/Clinical Community Oncology Program, Wichita, KS; Cancer Center of Columbus/Clinical Community Oncology Program, Columbus, OH; and Central Illinois Clinical Community Oncology Program, Decatur, IL.'], 'affiliations': [{'raw_affiliation_string': 'From the Genitourinary Medical Oncology Department and Department of Biostatistics, University of Texas M.D. Anderson Cancer Center, Houston, TX; Cancer Center of Wichita/Clinical Community Oncology Program, Wichita, KS; Cancer Center of Columbus/Clinical Community Oncology Program, Columbus, OH; and Central Illinois Clinical Community Oncology Program, Decatur, IL.', 'institution_ids': ['https://openalex.org/I4210165485']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103789081', 'display_name': 'J. Phillip Kuebler', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210165485', 'display_name': 'Columbus Community Clinical Oncology Program', 'ror': 'https://ror.org/05rvv6a54', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I4210165485']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'J. Phillip Kuebler', 'raw_affiliation_strings': ['From the Genitourinary Medical Oncology Department and Department of Biostatistics, University of Texas M.D. Anderson Cancer Center, Houston, TX; Cancer Center of Wichita/Clinical Community Oncology Program, Wichita, KS; Cancer Center of Columbus/Clinical Community Oncology Program, Columbus, OH; and Central Illinois Clinical Community Oncology Program, Decatur, IL.'], 'affiliations': [{'raw_affiliation_string': 'From the Genitourinary Medical Oncology Department and Department of Biostatistics, University of Texas M.D. Anderson Cancer Center, Houston, TX; Cancer Center of Wichita/Clinical Community Oncology Program, Wichita, KS; Cancer Center of Columbus/Clinical Community Oncology Program, Columbus, OH; and Central Illinois Clinical Community Oncology Program, Decatur, IL.', 'institution_ids': ['https://openalex.org/I4210165485']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5045807201', 'display_name': 'J Wade', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210165485', 'display_name': 'Columbus Community Clinical Oncology Program', 'ror': 'https://ror.org/05rvv6a54', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I4210165485']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'James Wade', 'raw_affiliation_strings': ['From the Genitourinary Medical Oncology Department and Department of Biostatistics, University of Texas M.D. Anderson Cancer Center, Houston, TX; Cancer Center of Wichita/Clinical Community Oncology Program, Wichita, KS; Cancer Center of Columbus/Clinical Community Oncology Program, Columbus, OH; and Central Illinois Clinical Community Oncology Program, Decatur, IL.'], 'affiliations': [{'raw_affiliation_string': 'From the Genitourinary Medical Oncology Department and Department of Biostatistics, University of Texas M.D. Anderson Cancer Center, Houston, TX; Cancer Center of Wichita/Clinical Community Oncology Program, Wichita, KS; Cancer Center of Columbus/Clinical Community Oncology Program, Columbus, OH; and Central Illinois Clinical Community Oncology Program, Decatur, IL.', 'institution_ids': ['https://openalex.org/I4210165485']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5008820123', 'display_name': 'Christopher J. Logothetis', 'orcid': 'https://orcid.org/0000-0002-6365-1711'}, 'institutions': [{'id': 'https://openalex.org/I4210165485', 'display_name': 'Columbus Community Clinical Oncology Program', 'ror': 'https://ror.org/05rvv6a54', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I4210165485']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Christopher J. Logothetis', 'raw_affiliation_strings': ['From the Genitourinary Medical Oncology Department and Department of Biostatistics, University of Texas M.D. Anderson Cancer Center, Houston, TX; Cancer Center of Wichita/Clinical Community Oncology Program, Wichita, KS; Cancer Center of Columbus/Clinical Community Oncology Program, Columbus, OH; and Central Illinois Clinical Community Oncology Program, Decatur, IL.'], 'affiliations': [{'raw_affiliation_string': 'From the Genitourinary Medical Oncology Department and Department of Biostatistics, University of Texas M.D. Anderson Cancer Center, Houston, TX; Cancer Center of Wichita/Clinical Community Oncology Program, Wichita, KS; Cancer Center of Columbus/Clinical Community Oncology Program, Columbus, OH; and Central Illinois Clinical Community Oncology Program, Decatur, IL.', 'institution_ids': ['https://openalex.org/I4210165485']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 4.91, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 41, 'citation_normalized_percentile': {'value': 0.826577, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 91, 'max': 92}, 'biblio': {'volume': '21', 'issue': '5', 'first_page': '878', 'last_page': '883'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10543', 'display_name': 'Advancements in Prostate Cancer Research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10543', 'display_name': 'Advancements in Prostate Cancer Research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10124', 'display_name': 'Prostate Cancer Research and Treatment', 'score': 0.9992, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11395', 'display_name': 'Development and Applications of Radiopharmaceuticals', 'score': 0.991, 'subfield': {'id': 'https://openalex.org/subfields/2741', 'display_name': 'Radiology, Nuclear Medicine and Imaging'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/estramustine', 'display_name': 'Estramustine', 'score': 0.71542823}, {'id': 'https://openalex.org/keywords/cancer-treatment', 'display_name': 'Cancer Treatment', 'score': 0.522564}, {'id': 'https://openalex.org/keywords/metastatic-prostate-cancer', 'display_name': 'Metastatic Prostate Cancer', 'score': 0.503051}, {'id': 'https://openalex.org/keywords/clinical-endpoint', 'display_name': 'Clinical endpoint', 'score': 0.4971178}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9213817}, {'id': 'https://openalex.org/C2780201970', 'wikidata': 'https://www.wikidata.org/wiki/Q412939', 'display_name': 'Estramustine', 'level': 5, 'score': 0.71542823}, {'id': 'https://openalex.org/C2780192828', 'wikidata': 'https://www.wikidata.org/wiki/Q181257', 'display_name': 'Prostate cancer', 'level': 3, 'score': 0.62130755}, {'id': 'https://openalex.org/C2781190966', 'wikidata': 'https://www.wikidata.org/wiki/Q420436', 'display_name': 'Docetaxel', 'level': 3, 'score': 0.51100814}, {'id': 'https://openalex.org/C203092338', 'wikidata': 'https://www.wikidata.org/wiki/Q1340863', 'display_name': 'Clinical endpoint', 'level': 3, 'score': 0.4971178}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.4870165}, {'id': 'https://openalex.org/C2776235491', 'wikidata': 'https://www.wikidata.org/wiki/Q9625', 'display_name': 'Prostate', 'level': 3, 'score': 0.45371023}, {'id': 'https://openalex.org/C2781064554', 'wikidata': 'https://www.wikidata.org/wiki/Q407883', 'display_name': 'Ketoconazole', 'level': 3, 'score': 0.45293266}, {'id': 'https://openalex.org/C168563851', 'wikidata': 'https://www.wikidata.org/wiki/Q1436668', 'display_name': 'Randomized controlled trial', 'level': 2, 'score': 0.42057335}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.41861635}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.3837983}, {'id': 'https://openalex.org/C141071460', 'wikidata': 'https://www.wikidata.org/wiki/Q40821', 'display_name': 'Surgery', 'level': 1, 'score': 0.3680381}, {'id': 'https://openalex.org/C126894567', 'wikidata': 'https://www.wikidata.org/wiki/Q105650', 'display_name': 'Urology', 'level': 1, 'score': 0.36802232}, {'id': 'https://openalex.org/C2779548794', 'wikidata': 'https://www.wikidata.org/wiki/Q578726', 'display_name': 'Antifungal', 'level': 2, 'score': 0.0}, {'id': 'https://openalex.org/C2994223898', 'wikidata': 'https://www.wikidata.org/wiki/Q9625', 'display_name': 'Prostate disease', 'level': 4, 'score': 0.0}, {'id': 'https://openalex.org/C16005928', 'wikidata': 'https://www.wikidata.org/wiki/Q171171', 'display_name': 'Dermatology', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000230', 'descriptor_name': 'Adenocarcinoma', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D011471', 'descriptor_name': 'Prostatic Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000230', 'descriptor_name': 'Adenocarcinoma', 'qualifier_ui': 'Q000556', 'qualifier_name': 'secondary', 'is_major_topic': False}, {'descriptor_ui': 'D000230', 'descriptor_name': 'Adenocarcinoma', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000369', 'descriptor_name': 'Aged, 80 and over', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004317', 'descriptor_name': 'Doxorubicin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004317', 'descriptor_name': 'Doxorubicin', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D019008', 'descriptor_name': 'Drug Resistance, Neoplasm', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004961', 'descriptor_name': 'Estramustine', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D004961', 'descriptor_name': 'Estramustine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005047', 'descriptor_name': 'Etoposide', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D005047', 'descriptor_name': 'Etoposide', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007654', 'descriptor_name': 'Ketoconazole', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D007654', 'descriptor_name': 'Ketoconazole', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009376', 'descriptor_name': 'Neoplasms, Hormone-Dependent', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017239', 'descriptor_name': 'Paclitaxel', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017239', 'descriptor_name': 'Paclitaxel', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D011446', 'descriptor_name': 'Prospective Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017430', 'descriptor_name': 'Prostate-Specific Antigen', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D017430', 'descriptor_name': 'Prostate-Specific Antigen', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011471', 'descriptor_name': 'Prostatic Neoplasms', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': False}, {'descriptor_ui': 'D011471', 'descriptor_name': 'Prostatic Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011788', 'descriptor_name': 'Quality of Life', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015996', 'descriptor_name': 'Survival Rate', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1200/jco.2003.04.057', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S15137598', 'display_name': 'Journal of Clinical Oncology', 'issn_l': '0732-183X', 'issn': ['0732-183X', '1527-7755'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/12610188', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.66, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 21, 'referenced_works': ['https://openalex.org/W1513618424', 'https://openalex.org/W1905912155', 'https://openalex.org/W1941767745', 'https://openalex.org/W1966714873', 'https://openalex.org/W1979300931', 'https://openalex.org/W1984749582', 'https://openalex.org/W2024081693', 'https://openalex.org/W2029409133', 'https://openalex.org/W2042542641', 'https://openalex.org/W2058120885', 'https://openalex.org/W2069950565', 'https://openalex.org/W2087039456', 'https://openalex.org/W2093333853', 'https://openalex.org/W2139984188', 'https://openalex.org/W2155679349', 'https://openalex.org/W2163014310', 'https://openalex.org/W3147894994', 'https://openalex.org/W4236448925', 'https://openalex.org/W4285719527', 'https://openalex.org/W4293241248', 'https://openalex.org/W79536663'], 'related_works': ['https://openalex.org/W4236858530', 'https://openalex.org/W2735900144', 'https://openalex.org/W2588988563', 'https://openalex.org/W2395356090', 'https://openalex.org/W2338595158', 'https://openalex.org/W2155169688', 'https://openalex.org/W2094570582', 'https://openalex.org/W2010765098', 'https://openalex.org/W1988406497', 'https://openalex.org/W1966846135'], 'abstract_inverted_index': {'Purpose:': [0], 'Several': [1], 'multicomponent': [2], 'regimens': [3, 188, 222, 251], 'have': [4], 'been': [5], 'reported': [6], 'to': [7, 22, 49, 132, 145, 158, 170, 252], 'be': [8, 224], 'useful': [9], 'in': [10, 33, 98, 121, 148, 211, 256], 'advanced': [11], 'androgen-independent': [12, 43], 'prostate': [13, 44], 'cancer.': [14], 'We': [15], 'used': [16], 'a': [17], 'randomized': [18], 'phase': [19, 253], 'II': [20], 'design': [21], 'evaluate': [23], 'and': [24, 38, 63, 83, 152, 193, 227, 236], 'compare': [25], 'two': [26, 52], 'such': [27], 'regimens.': [28], 'Patients': [29, 37, 40, 67], 'were': [30, 46, 68, 81, 93], 'accrued': [31], 'primarily': [32], 'the': [34, 72, 99, 102, 122, 149, 194, 212, 237, 257], 'community': [35, 213], 'setting.': [36, 214, 260], 'Methods:': [39], 'with': [41, 57, 164, 206], 'progressive,': [42], 'cancer': [45], 'randomly': [47], 'assigned': [48, 131], 'one': [50], 'of': [51, 74, 90, 104, 118, 129, 176, 186, 239, 249], 'treatments:': [53], 'either': [54, 248], 'ketoconazole/doxorubicin': [55], 'alternating': [56], 'vinblastine/estramustine': [58], '(KA/VE)': [59], 'or': [60], 'paclitaxel,': [61], 'estramustine,': [62], 'oral': [64], 'etoposide': [65], '(TEE).': [66], 'prospectively': [69], 'stratified': [70], 'on': [71], 'basis': [73], 'disease': [75], 'volume.': [76], 'The': [77], 'primary': [78], 'end': [79], 'points': [80], 'response': [82], 'overall': [84], 'survival': [85, 136, 197], 'time.': [86], 'Results:': [87], 'A': [88], 'total': [89], '75': [91], 'patients': [92, 120, 162, 167], 'registered;': [94], '71': [95, 202], 'are': [96], 'included': [97], 'analysis.': [100], 'By': [101], 'criterion': [103], 'an': [105], '80%': [106], 'prostate-specific': [107], 'antigen': [108], 'reduction': [109], 'maintained': [110], 'for': [111, 161, 200], 'at': [112, 172, 232], 'least': [113, 173], '8': [114], 'weeks,': [115], '11': [116, 127], '(30%)': [117], '37': [119], 'TEE': [123, 150], 'arm': [124, 151], 'responded,': [125], 'whereas': [126], '(32%)': [128], '34': [130], 'KA/VE': [133], 'responded.': [134], 'Median': [135], 'was': [137], '16.9': [138], 'months': [139, 154, 199], '(95%': [140, 155], 'confidence': [141], 'interval': [142], '[CI],': [143], '10.5': [144], '21.2': [146], 'months)': [147, 160], '23.4': [153], 'CI,': [156], '12.9': [157], '30.6': [159], 'treated': [163], 'KA/VE.': [165], 'Many': [166], '(24%)': [168], 'failed': [169], 'complete': [171], '6': [174], 'weeks': [175], 'therapy,': [177], 'including': [178], 'five': [179], '(8%)': [180], 'treatment-related': [181], 'early': [182], 'deaths.': [183], 'Conclusion:': [184], 'Each': [185], 'these': [187, 220, 250], 'produced': [189], 'clinically': [190], 'significant': [191], 'responses,': [192], 'observed': [195], 'median': [196], '(18.9': [198], 'all': [201], 'patients)': [203], 'compares': [204], 'favorably': [205], 'previously': [207], 'published': [208], 'results,': [209], 'especially': [210], 'Nonetheless,': [215], 'it': [216], 'is': [217], 'apparent': [218], 'that': [219], 'first-generation': [221], 'must': [223], 'applied': [225], 'judiciously,': [226], 'thus': [228], 'we': [229], 'view': [230], 'efforts': [231], 'better': [233], 'patient': [234], 'selection': [235], 'development': [238], 'more': [240], 'tolerable': [241], 'therapies': [242], 'as': [243], 'higher': [244], 'priorities': [245], 'than': [246], 'carrying': [247], 'III': [254], 'evaluation': [255], 'cooperative': [258], 'group': [259]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2084009328', 'counts_by_year': [{'year': 2022, 'cited_by_count': 3}, {'year': 2019, 'cited_by_count': 2}, {'year': 2016, 'cited_by_count': 1}, {'year': 2015, 'cited_by_count': 2}, {'year': 2012, 'cited_by_count': 2}], 'updated_date': '2024-09-18T13:08:59.318706', 'created_date': '2016-06-24'}